Abstract: Science Set Journal of Medical and Clinical Case Studies

Abstract:
Advances in medical knowledge and better realizing disease processes are directing the search for early diagnosis/ imaging methods and new therapy choices. Theranostics (or Theragnostic as it is a connection of Therapy and Diagnosis) is the combination of diagnostic imaging with targeted therapy and is, nowadays, becoming more widely applied. The study of theranostics combines molecular imaging with targeted radionuclide therapy, which involves the use of small molecules, peptides and/or antibodies as carriers for therapeutic radionuclides. SPECT/CT and PET/CT hybrid studies are critical for use in medical conditions where isotopes detect life-threatening. Greater quantities of radioisotope products in centers, around the world, are necessary. There is also a shift towards reduced dependence on long-distance transport of radioisotope products. Clinicians increasingly seek to noninvasively inspection of tumour phenotypes and estimation of functional and molecular responses to therapy.